PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Battelino, T.* ; Lalic, N.* ; Hussain, S.* ; Ceriello, A.* ; Klobucar, S.* ; Davies, S.J.* ; Topsever, P.* ; Heverly, J.* ; Ulivi, F.* ; Brady, K.* ; Tankova, T.* ; Galhardo, J.* ; Tagkalos, K.* ; Werson, E.* ; Mathieu, C.* ; Schwarz, P.E.

The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes.

Diabetes Res. Clin. Pract. 223:112111 (2025)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
A global trend towards increased obesity, intermediate hyperglycemia (previously termed prediabetes) and type 2 diabetes, has prompted a range of international initiatives to proactively raise awareness and provide action-driven recommendations to prevent and manage these linked disease states. One approach, that has shown success in managing people already diagnosed with type 2 diabetes mellitus, is to use continuous glucose monitoring (CGM) devices to help them manage their chronic condition through understanding and treating their daily glucose fluctuations, in assocation with glucose-lowering medications, including insulin. However, much of the burden of type 2 diabetes mellitus is founded in the delayed detection both of type 2 diabetes mellitus itself, and the intermediate hyperglycaemia that precedes it. In this review, we provide evidence that using CGM technology in people at-risk of intermediate hyperglycaemia or type 2 diabetes mellitus can significantly improve the rate and timing of detection of dysglycaemia. Earlier detection allows intervention, including through continued use of CGM to guide changes to diet and lifestyle, that can delay or prevent harmful progression of early dysglycaemia. Although further research is needed to fully understand the cost-effectiveness of this intervention in people at-risk or with early dysglycemia, the proposition for use of CGM technology is clear.
Impact Factor
Scopus SNIP
Altmetric
7.400
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Consensus Statements ; Continuous Glucose Monitoring ; Intermediate Hyperglycemia ; Obesity ; Prediabetes ; Type 2 Diabetes; Life-style Intervention; Follow-up; Glycemic Variability; Microvascular Complications; Severe Hypoglycemia; Insulin Injections; Consensus Report; Time; Association; Risk
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0168-8227
e-ISSN 1872-8227
Zeitschrift Diabetes Research and Clinical Practice
Quellenangaben Band: 223, Heft: , Seiten: , Artikelnummer: 112111 Supplement: ,
Verlag Elsevier
Verlagsort Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-004
Förderungen Medical Research Council Clinical Academic Partnership award
Slovenian Research and Inovation Agency
DOI 10.1016/j.diabres.2025.112111
WOS ID 001481396700001
Scopus ID 105001939592
PubMed ID 40118193
Erfassungsdatum 2025-05-09
[➜Korrektur melden]